@mjwsim @iskander @hammer_lab @GenScript We are just following the footsteps of this Genentech paper on MC38 neoepitopes: https://t.co/BlJrz1HRzX We used their "top" hits as a starting point (see that table in the first tweet). We were hoping that our new
@Festivus159 Did you see this study from Genentech last November? Interesting angle to come at it: http://t.co/RzNuO78R1u
Adap: Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.: Related… http://t.co/jBMZTcz5BQ
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. http://t.co/fzLojHmrHO
Tumor immunology from @genentech: predicting which mutations will stimulate immune system's anti-cancer reaction http://t.co/jUU6TDVGWJ
Tumor immunology from @genentech: predicting which mutations will stimulate immune system's anti-cancer reaction http://t.co/jUU6TDVGWJ
Tumor immunology from @genentech: predicting which mutations will stimulate immune system's anti-cancer reaction http://t.co/jUU6TDVGWJ
Mutant immunogenic epitopes in cancer, analysed with #EnsemblVEP #CitedEnsembl @nature http://t.co/TnSYdpX2tu
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing http://t.co/nEp1QQKrG5
Predicting Immunogenic Tumor Mutations by Combining Mass Spectrometry and Exome Sequencing @genentech @Nature http://t.co/45RYLj2NmR
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing… http://t.co/YN2nal8GV4
Defining immunity to transformed self: detecting immunogenic class I MHC neo-antigens arising from cancer mutations. http://t.co/3Tx1MBOu09
Defining immunity to transformed self: detecting immunogenic class I MHC neo-antigens arising from cancer mutations. http://t.co/3Tx1MBOu09
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. http://t.co/wSMjMRidCz
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
#JuevesDeNature mutaciones tumorales inmunogénicas combinación de #espectrometríademasas #secuenciación del #exoma http://t.co/uo6KE0h9Oe
#JuevesDeNature mutaciones tumorales inmunogénicas combinación de #espectrometríademasas #secuenciación del #exoma http://t.co/uo6KE0h9Oe
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Tumor immunology from @genentech: predicting which mutations will stimulate immune system's anti-cancer reaction http://t.co/jUU6TDVGWJ
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
Could this new approach to predicting immune response to cancer offer clues on #immunotherapy? http://t.co/QNXWfD6d4T @Nature
"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing" http://t.co/PLVhLpSdwN
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing http://t.co/i8pHhIsYLV
Just out in @nature "Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing" http://t.co/OLFg8L4zvK
Just out in @nature "Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing" http://t.co/OLFg8L4zvK
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing… http://t.co/3CZ9DQsPl8
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing http://t.co/5NRKxZm0Aw #natureTCB
Really cool paper with potential for personal cancer vaccines. http://t.co/Z5Ej7bAmxD
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing http://t.co/159Btlxnuy